Skip to content
Open access · OA via OpenAlex

Senolytic Development in Osteoarthritis: A New Paradigm

Authors not listed

Integrative Journal of Orthopaedics and Traumatology · 2021

Abstract

advances in the biology of aging will be at the origin of therapeutical improvement making it possible to increase life expectancy in good health and prevent OA. Senescence(definition) and OA PhysiopathologySenescence is a complex pathophysiological phenomenon that can be observed in the context of tissue damage associated with aging in the context of cancer development.Cellular senescence is a cell Abstract OA is a large unmet medical need, with increasing incidence in our aging population.Recent physiopathogical knowledge have identified the accumulation of senolytic cells in cartilage and the synovium as deleterious.This has prompted the development of senolytic drugs in OA.Senolytics(definition) are a class of drugs that selectively clear senescent cells.Senolytics induce apoptosis of senescent cells accumulated in joint tissue with a tissue-destructive SASP (senescent associated secreted proteome).They include three major classes of molecules.Senolytics which seek to kill/eliminate senescent cells by playing on increased cell survival pathways during the senescence process.Seno-morphics, which change the inherent properties of the senescent state, for example by reactivating autophagy(definition) while maintaining the stopping of the cycle.And finally, a third class of therapeutic agents, senosuppressants, will block the entry or the spread of senescence.Thus, drugs with senotherapy properties such as metformin, mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition), fisetin, dasatinib, quercetin, resveratrol, have shown modulation of the aging process and associated pathologies including OA.Thus, many therapeutic alternatives in the treatment of osteoarthritis are opening up, but clinical trials will have to be carried out to confirm their effectiveness.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.31038/ijot.2021422
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Anonymous. (2021). Senolytic Development in Osteoarthritis: A New Paradigm. <em>Integrative Journal of Orthopaedics and Traumatology</em>. https://doi.org/10.31038/ijot.2021422
Vancouver
Anonymous. Senolytic Development in Osteoarthritis: A New Paradigm. Integrative Journal of Orthopaedics and Traumatology. 2021. doi:10.31038/ijot.2021422.
BibTeX
@article{anon2021Senoly, title = {Senolytic Development in Osteoarthritis: A New Paradigm}, author = {Anonymous}, journal = {Integrative Journal of Orthopaedics and Traumatology}, year = {2021}, doi = {10.31038/ijot.2021422}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings